Profile
Ms. Jennifer E.
Pardi is a Managing Director, Global Head of Equity Capital Markets & Co-Head of US Securities at Canaccord Genuity LLC.
She is responsible for oversight of Canaccord Genuity’s global ECM activities, with a focus on driving coordination and best practices across all regions to drive optimal outcomes for our corporate and institutional clients.
Ms. Pardi was previously employed as an Independent Director by GreenLight Biosciences Holdings PBC.
She also served on the board at Environmental Impact Acquisition Corp.
She received her undergraduate degree from the University of Connecticut and an MBA from Suffolk University.
Jennifer Pardi active positions
| Companies | Position | Start |
|---|---|---|
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Director of Research - Equity | 01/09/2003 |
Former positions of Jennifer Pardi
| Companies | Position | End |
|---|---|---|
| GREENLIGHT BIOSCIENCES HOLDINGS | Director/Board Member | 24/07/2023 |
| GREENLIGHT BIOSCIENCES HOLDINGS PBC | Director/Board Member | - |
Training of Jennifer Pardi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Suffolk University
Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Environmental Impact Acquisition Corp.
Environmental Impact Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
GreenLight Biosciences Holdings PBC
GreenLight Biosciences Holdings PBC BiotechnologyHealth Technology Operates as a biotechnology company that develops ribonucleic acid products | Health Technology |
- Stock Market
- Insiders
- Jennifer Pardi
















